Dr. Rosenblit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
18821 Delaware St
Suite 202
Huntington Beach, CA 92648Phone+1 714-375-5572Fax+1 714-375-5575
Summary
- Board-certified in Endocrinology and Metabolism, subspecialty-trained at UCLA, I have been in a private practice of general endocrinology, that includes pituitary, thyroid, adrenal, gonadal disorders, osteoporosis, and other metabolic disorders. Special interest includes an emphasis on diabetes, lipid management, and preventive cardiology as a board-certified Clinical Lipidologist.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1986
- AtlantiCare Regional Medical CenterResidency, Internal Medicine, 1982 - 1984
- AtlantiCare Regional Medical CenterInternship, Internal Medicine, 1981 - 1982
- Universidad Autonoma de Ciudad JuarezClass of 1981
Certifications & Licensure
- CA State Medical License 1982 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- American Board of Clinical LipidologyClinical Lipidology
Awards, Honors, & Recognition
- Fellow (FNLA) National Lipid Association, 2009
- Top MD Consumers Checkbook
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 122 citationsConsensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of ...Yehuda Handelsman, Paul S. Jellinger, Chris K. Guerin, Zachary T. Bloomgarden, Eliot A. Brinton
Endocrine Practice. 2020-10-01 - 335 citationsCONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGO...Alan J. Garber, Yehuda Handelsman, George Grunberger, Daniel Einhorn, Martin J. Abrahamson
Endocrine Practice. 2020-01-01 - 6 citationsLowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at “Extreme” ASCVD RiskPaul D. Rosenblit
Current Diabetes Reports. 2019-11-21
Committees
- member, AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2035
- member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN 2015
- member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015
- member, 2011 AACE Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan
- member, CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM 2016 EXECUTIVE SUMMARY
- member, American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical Practice Guidelines for Developing a Diabetes Mellitus Comprehensive Care Plan 2015
Professional Memberships
- Member
- Member
- Member
- Member
- Member
- American Society of Preventive CardiologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: